Go to the list of all blogs
Niko Sharks's Avatar
published in Blogs
Aug 08, 2023
TickeronGET DAILY SIGNALS

Nuclear Sector Stocks ( $HII,$PESI, $WVE) Shine with a strong performance Over the Past Month

The nuclear sector encompasses a wide array of businesses essential to the modern world. This includes companies such as Centrus Energy Corp., which supplies enriched uranium for commercial nuclear power plants. Perma-Fix Environmental Services, Inc. plays a crucial role in nuclear and industrial waste management. On the other hand, Huntington Ingalls Industries Inc. is at the forefront of designing and maintaining nuclear ships.You can find more information and access the data on these companies in our robot at Swing trader: High Capitalization (TA)

Market Capitalization: Within the nuclear theme, the market dynamics are diverse. The average market capitalization stands at 2.5B. The spectrum ranges from behemoths like HII with a valuation of 9B to smaller players like GVP, valued at just 11.1M.

Notable Price Movements: In terms of price action, the average weekly growth rate for the nuclear stocks was 9%. On a monthly scale, this figure jumps to 17.92% and settles at 16.91% for the quarterly rate. Among the major movers, GVP led the pack with a stellar 24.61% growth. Conversely, HII saw a dip, recording a decline of -1.57%.

Recent highlights include:

  • BWX Technologies (BWXT, $73.85) emerging as a top performer with a weekly surge of +7.5% as of 8/5/23.
  • Wave Life Sciences (WVE, $3.74) facing headwinds, dropping by -6.03% in the week of 6/24/23.

Volume Analysis: Trading volumes provide insights into the liquidity and interest in these stocks. The weekly volume growth rate averaged at 186.29%. Monthly and quarterly figures were 134.62% and 191.55%, respectively. A notable event was on 6/16/23 when BWX Technologies stock witnessed a significant surge in trading activity, with volumes increasing consecutively over four days. This culminated in a record-breaking growth, touching 99% of the 65-Day Volume Moving Average.

Fundamental Analysis Ratings: When analyzing stocks, fundamental analysis offers a deep dive into a company's intrinsic value. While the specific ratings weren't provided, it's evident that within the nuclear sector, some stocks fare better than others based on their fundamentals. For investors, these ratings can serve as a guiding tool to evaluate the long-term prospects and health of the companies in the sector.

In summary, the nuclear sector presents a robust growth story, with companies experiencing significant gains and increased trading volumes. This trend highlights the sector's increasing relevance and potential in today's market landscape.

Huntington Ingalls Industries (HII)

Huntington Ingalls Industries (HII) achieved a significant milestone on July 31, 2023, when its 50-day moving average crossed above the 200-day moving average. This pattern, known as a "Golden Crossover," is frequently interpreted as a long-term bullish signal, indicating a potential shift in HII's stock towards an upward trend. The development may draw the attention of investors looking to capitalize on the momentum.

Perma-Fix Environmental Services Inc. (PESI)

On July 31, 2023, the Relative Strength Index (RSI) for Perma-Fix Environmental Services Inc. (PESI) ascended out of oversold territory, often viewed as a shift from a downward to an upward trend. Historical analysis from A.I.dvisor shows that in 19 out of 26 similar occurrences, the stock moved higher, presenting a 73% likelihood of a continued upward move. Traders may consider this as a cue to potentially buy the stock or call options, aligning with the historical pattern.

BWX Technologies (BWXT)

On August 04, 2023, BWX Technologies' (BWXT) MACD Histogram signaled a bullish turn by crossing above its signal line. Historical data shows that following similar positive MACD shifts, BWXT's stock experienced growth in 28 out of 44 instances in the subsequent month. This gives a 64% probability of an ongoing upward trend. Investors might view this as an encouraging sign for potential growth.

 

Related Ticker: WVE, HII, PESI, LEU, BWXT

WVE's Indicator enters downward trend

The Aroon Indicator for WVE entered a downward trend on October 23, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 217 similar instances where the Aroon Indicator formed such a pattern. In 202 of the 217 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WVE as a result. In 70 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

The Moving Average Convergence Divergence Histogram (MACD) for WVE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 47 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +8.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where WVE advanced for three days, in 206 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

WVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.462) is normal, around the industry mean (3.596). P/E Ratio (-3.116) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (12.953) is also within normal values, averaging (443.347).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. WVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.24B. The market cap for tickers in the group ranges from 58 to 138.67B. VRTX holds the highest valuation in this group at 138.67B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -12%. For the same Industry, the average monthly price growth was -18%, and the average quarterly price growth was -28%. VIVS experienced the highest price growth at 105%, while CUE experienced the biggest fall at -74%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 37%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was -10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 44
Price Growth Rating: 69
SMR Rating: 93
Profit Risk Rating: 93
Seasonality Score: -3 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of nucleic acid therapeutics

Industry Biotechnology

Industry
Biotechnology
Address
733 Concord Avenue
Phone
+1 617 949-2900
Employees
317
Web
https://www.wavelifesciences.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.